| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 03/08/2005 | CA2134009C Bicyclic amidines, process for their preparation, and their use as catalyst |
| 03/03/2005 | WO2005019222A1 4-cycloalkylaminopyrazolo pyrimidine nmda/nr2b antagonists |
| 03/03/2005 | WO2005019221A1 4-cycloalkylaminopyrazolo pyrimidine nmda/nr2b antagonists |
| 03/03/2005 | WO2005019220A2 Substituted imidazo[1,2-a]pyrazines as modulators of kinase activity |
| 03/03/2005 | WO2005019219A1 Pyrrolopyrimidinone derivative |
| 03/03/2005 | WO2005019218A1 Pyrrolopyrimidinethione derivative |
| 03/03/2005 | WO2005019211A2 Biaryl heterocyclic compounds and methods of making and using the same |
| 03/03/2005 | WO2005019202A1 Substituted pyrimdinone derivatives and methods of use |
| 03/03/2005 | WO2005018532A2 Purine receptor binding compounds |
| 03/03/2005 | WO2005018531A2 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof |
| 03/03/2005 | WO2004093812A3 Compounds that induce neuronal differentiation in embryonic stem cells |
| 03/03/2005 | WO2004082606A8 Fused pyrrole compounds |
| 03/03/2005 | WO2004001058A3 Transcription factor modulating compounds and methods of use thereof |
| 03/03/2005 | US20050049292 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression |
| 03/03/2005 | US20050049262 Substituted 2,5-dioxopurines, 2H-1,2,3-triazolyl[4,5-d]pyrimidines, or 1,2,5-thadiazolyl[3,4-d]pyrimidines; antiproliferative, antiinflammatory, and antiarthritic agents; psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, lupus, graft versus host disease |
| 03/03/2005 | US20050049261 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 03/03/2005 | US20050049253 Substituted quinolinone derivatives and methods of use |
| 03/03/2005 | US20050049250 7-Aikyl and cycloalkyl-substituted imidazotriazinones |
| 03/03/2005 | DE10339629A1 Process to encapsulate an organic electronic component with a layer of hydrophobic, linear or two-dimensional polycyclic aromatic material |
| 03/03/2005 | CA2535644A1 Substituted pyrimdinone derivatives and methods of use |
| 03/03/2005 | CA2535347A1 4-cycloalkylaminopyrazolo pyrimidine nmda/nr2b antagonists |
| 03/03/2005 | CA2528089A1 Biaryl heterocyclic compounds and methods of making and using the same |
| 03/02/2005 | EP1510519A1 Pharmaceutical compositions comprising 2,3-diarylpyrazolo[1,5-B]pyridazine derivatives |
| 03/02/2005 | EP1510516A1 Pyrazole compound and medicinal composition containing the same |
| 03/02/2005 | EP1509528A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 03/02/2005 | EP1509527A2 Preparation of metal mesoporphyrin halide compounds |
| 03/02/2005 | EP1509526A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509218A1 Peptide deformylase inhibitors |
| 03/02/2005 | EP1278741B1 Muscarinic agonists |
| 03/02/2005 | EP1238979B1 Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same |
| 03/02/2005 | EP1165563B1 Bicyclic heterocycles, method for producing them and their use as herbicides and pharmaceutical agents |
| 03/02/2005 | EP1070067B1 Cytotoxic alkaloid derivatives including asmarine a and b isolated from a sponge |
| 03/02/2005 | CN1589273A The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 03/02/2005 | CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function |
| 03/02/2005 | CN1589238A Process for the microbiological decontamination of water by means of photosensitive agents |
| 03/02/2005 | CN1191255C Benzodiazepine derivatives as GABA A receptor modulators |
| 03/02/2005 | CN1191254C Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof |
| 03/01/2005 | US6861529 Cycloalkylpyrrole-3-carboxylic acid amide derivatives and heterocycloalkylpyrrole-3-carboxylic acid amide derivatives that bind with high affinity to the benzodiazepine site of GABA-A (gamma-aminobutyric acid) receptors |
| 03/01/2005 | US6861429 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 03/01/2005 | US6861425 Benzimidazole compounds as ORL1-receptor agonists |
| 03/01/2005 | US6861418 Modulating protein kinase signal transduction; anticancer agents |
| 03/01/2005 | US6861162 Organic electroluminescence devices using pyrazolo[3,4b]quinoxaline derivatives |
| 03/01/2005 | US6861043 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 02/24/2005 | WO2005017124A2 Peptide deformylase inhibitors |
| 02/24/2005 | WO2005016933A1 4-biphenyl-substituted 4-substituted pyrazolidin-3,5-diones pesticide agent and/or microbicide and/or herbicide |
| 02/24/2005 | WO2005016929A1 Fused heterocylcles as inhibitors of glutamate racemase (muri) |
| 02/24/2005 | WO2005016927A1 Nitrogenous condensed-ring compound and use thereof as hiv integrase inhibitor |
| 02/24/2005 | WO2005016892A1 Gabanergic modulators |
| 02/24/2005 | WO2005016878A2 METHODS FOR THE PREPARATION OF 5-FLUORO-PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 02/24/2005 | WO2005016873A2 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016235A2 Combined use of impdh inhibitors with toll-like receptor agonists |
| 02/24/2005 | WO2005016000A1 Derivatives of cyclic quinone and uses thereof |
| 02/24/2005 | WO2005003133A3 Method for producing alkoxy-substituted phthalocyanins |
| 02/24/2005 | WO2004096235A8 Anti-cancer phosphonate analogs |
| 02/24/2005 | WO2004087056A3 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ |
| 02/24/2005 | US20050043544 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 02/24/2005 | US20050043509 Peptoid compounds |
| 02/24/2005 | US20050043354 Substance P antagonist |
| 02/24/2005 | US20050043332 Such as 4 (cis-3-hydroxycyclopentyl)amino-5,6-dimethyl-2-phenyl-7H-pyrrolo[2,3d] pyrimidine for treatment of adenosine receptor stimulated diseases, cardiovascular disorders, and nervous system disorders |
| 02/24/2005 | US20050043331 Substituted 3-(2,5-disubstituted)pyridyl-4-aryl pyrroles for treating inflammatory diseases |
| 02/24/2005 | US20050043325 Novel pharmaceuticals |
| 02/24/2005 | US20050043317 Biaryl heterocyclic compounds and methods of making and using the same |
| 02/24/2005 | US20050043311 6(5-chloro-2-pyridyl-)-5-[4-methyl-1-piperazinyl]carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine for tranquilizers or hypnotics |
| 02/24/2005 | US20050043306 Heterocyclic drugs as enzyme inhibitors for Kinase enzymes or prodrugs |
| 02/24/2005 | US20050043303 prophylaxis of cardiovascular disorders comprising administering to mammals inhibitors of cyclic guanosine monophosphate metabolizing phosphodiesterases such as 2-{2-Ethoxy-5-[4-(2-hydroxy-ethyl)-piperazine-1-sulfonyl]-phenyl}-6-methyl-8-propyl-3H-imidazo[1,5-a][1,3,5]triazin-4-one; antiarrythmic agents |
| 02/24/2005 | US20050043301 Substituted heterocyclic compounds and methods of use |
| 02/24/2005 | US20050041494 High density non-volatile memory device |
| 02/24/2005 | DE4323942B4 Neue polycyclische Polyamide als Vorstufen für energetische polycyclische Polynitramin-Oxidationsmittel New polycyclic polyamides as precursors for energy polycyclic Polynitramin-oxidant |
| 02/24/2005 | DE10333935A1 Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New bicyclic Cyanoheterocyclen, processes for their preparation and their use as medicaments |
| 02/24/2005 | CA2577239A1 Nitrogen-containing fused ring compound and use thereof as hiv integraseinhibitor |
| 02/24/2005 | CA2535868A1 4-biphenyl-substituted 4-substituted pyrazolidin-3,5-diones pesticide agent and/or microbicide and/or herbicide |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2535512A1 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives |
| 02/24/2005 | CA2535406A1 Gabanergic modulators |
| 02/23/2005 | EP1508570A1 Novel physiolgically active substances |
| 02/23/2005 | EP1507781A2 Process for preparing maytansinol |
| 02/23/2005 | EP1507780A1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | EP1274710B1 Novel heteroaryl-diazabicycloalkanes |
| 02/23/2005 | EP1177177B1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands |
| 02/23/2005 | EP1129092B1 Porphyrin compounds, their conjugates and assay methods based on the use of said conjugates |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | CN1585977A Writable high-capacity optical storage media containing metal complexes |
| 02/23/2005 | CN1585771A Polycyclic guanine derivative phosphodiesterase V inhibitors |
| 02/23/2005 | CN1585770A Reverse-turn mimetics and method relating thereto |
| 02/23/2005 | CN1585744A Process for the preparation of benazepril |
| 02/23/2005 | CN1585636A Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 02/23/2005 | CN1583762A Axial substituted phthalocyanine compound, its preparation and application in optical kinetic treatment |
| 02/23/2005 | CN1583748A Metalphthalocyanine derivative, salt and preparing method thereof |
| 02/23/2005 | CN1583747A Pterin mononitrogen monoxide synthase inhibitor |
| 02/23/2005 | CN1190437C Pteridine compounds for treatment of psoriasis |
| 02/22/2005 | US6858727 Intermediate of carbapenem antibiotics and process for the preparation thereof |
| 02/22/2005 | US6858641 Substituted indolinones |
| 02/22/2005 | US6858623 Amidino and guanidino peptidyl compounds |
| 02/22/2005 | US6858616 Anticoagulant drug |
| 02/22/2005 | US6858604 Cyclohepta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
| 02/22/2005 | US6858380 Silver halide color photosensitive material |
| 02/22/2005 | US6858073 Transition metal or silicon matrix in which particles of an organic pigment are homogeneously embedded or crosslinked; 3-methylidene-2,3-dihydro-indol-2-ones, quinacridone, indigo, diketopyrrolopyrrole, anthraquinone, perylene; thermostable |